Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
11/2005
11/03/2005CA2559237A1 Novel alkyne compounds having an mch-antagonistic effect and medicaments containing said compounds
11/03/2005CA2559021A1 Novel alkyne compounds with an mch-antagonistic action and medicaments containing said compounds
11/03/2005CA2558755A1 Novel alkyne compounds having an mch-antagonistic effect, and medicaments containing said compounds
11/03/2005CA2557739A1 Uses of melanocortin-4 receptor (mc4r) agonist peptides administered by continuous infusion
11/02/2005EP1591437A2 Interleukin-1 and tumor necrosis factor-alpha modulators, syntheses of said modulators and methods of using said modulators
11/02/2005EP1591120A1 Receptor agonists
11/02/2005EP1591116A1 Inhibitor for perioperative blood sugar elevation
11/02/2005EP1591115A1 Preventive or remedy for intrauterine late embryonic development or pregnancy toxemia
11/02/2005EP1590674A2 Screening for modulators of fat storage
11/02/2005EP1590338A2 Modulators of melanocortin receptor
11/02/2005EP1590334A1 2,4-diaminopyrimidine derivatives useful as inhibitors of pkc-theta
11/02/2005EP1590333A1 Glycogen synthase kinase 3beta inhibitor, composition and process for the preparation thereof
11/02/2005EP1590326A2 Substituted alkyl amido piperidines
11/02/2005EP1590046A2 Composition for the treatment of hiv or aids
11/02/2005EP1589991A1 Long acting insulin for reducing cardiovascular morbidity and mortality in prediabetic patients and patients with type 2 diabetes
11/02/2005EP1589983A1 A process of preparing an extract of annona squamosa for the treatment of diabetes
11/02/2005EP1589969A2 3-amino-4-phenylbutanoic acid derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
11/02/2005EP1589964A1 Compounds having anti-proliferative properties
11/02/2005EP1589815A2 POLYCOSANOLS FROM i ERICERUS PELA /i WAX
11/02/2005EP1513813B1 Opioid receptor antagonists
11/02/2005EP1507758B1 Indole derivatives and their use as ligands for cb2 receptors
11/02/2005EP1501833B1 N-substituted-heteroaryloxy-aryl-spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors
11/02/2005EP1501525B1 Method for producing preparations rich in tocotrienol
11/02/2005EP1501515B1 Triaryl-oxy-aryloxy-pyrimidine-2,4,6-trione metalloproteinase inhibitors
11/02/2005EP1425007B1 Use of c2-substituted indane-1-ol systems for producing medicaments for the prophylaxis or treatment of obesity
11/02/2005EP1377569B1 Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines with adenosine receptor-binding activity and their use as cardiovascular preparations
11/02/2005EP1332149B1 Glycerophosphoinositol derivatives as modulators of cytosolic a2 phospholipase
11/02/2005EP1278719B1 Naphthamide neurokinin antagonists for use as medicaments
11/02/2005EP1246807B1 Novel hydantoin, thiohydantoin, pyrimidinedione and thioxopyrimidinone derivatives, preparation method and use as medicines
11/02/2005EP1237902B1 Halogenated sulphamate-, phosphonate-, thiophosphonate-, sulphonate- and sulphonamide- compounds as inhibitors of steroid sulphatase
11/02/2005EP1157000B1 Branched chain amino acid-dependent aminotransferase inhibitors and their use in the treatment of diabetic retinopathy
11/02/2005EP1083905B1 Medical use of a selective estrogen receptor modulator in combination with a sex steroide precursor
11/02/2005EP1080095B1 Modulators of protein tyrosine phosphatases (ptpases)
11/02/2005EP0929520B1 Indolinone combinatorial libraries and related products and methods for the treatment of disease
11/02/2005EP0601135B1 Osteogenic proteins in the treatment of metabolic bone diseases
11/02/2005CN1692102A Substituted 4-(indazol-3-yl)phenols as estrogen receptor (er) ligands and their use in the treatment of inflammatory diseases
11/02/2005CN1691958A Enos mutants useful for gene therapy
11/02/2005CN1691957A 蛋白酶抑制剂 Protease inhibitors
11/02/2005CN1691945A Use of rapamycin for inhibiting of cell death
11/02/2005CN1691939A Compositions for diabetes
11/02/2005CN1690057A Selenophen derivatives and their use for prevention and/or treatment of diseases relative to protein aging
11/02/2005CN1225175C Milk for lowering sugar and producing method thereof
11/01/2005US6960688 Use of compounds for the elevation of pyruvate dehydrogenase activity
11/01/2005US6960648 Peptide transporters that specifically target certain cell types for the delivery of drugs and therapeutic agents
11/01/2005US6960646 Cyclic peptides as potent and selective melanocortin-4 receptors agonists
11/01/2005US6960605 Thiazole, imidazole and oxazole compounds and treatments of disorders associated with protein aging
11/01/2005US6960602 Piperidine derivatives as modulators of chemokine receptors
11/01/2005US6960601 Imidazole derivatives; appetite suppressants
11/01/2005US6960590 Orally active salts with tyrosine kinase activity
11/01/2005US6960582 Such as (3S)-N-(2-(2-(2,4-dichlorophenyl)ethyl)-1-oxo-2,3-dihydro-1H-isoindol-5-yl) -3-methyl-N'-((1S,2S,3S,5R)-2,6,6-trimethylbicyclo(3.1.1)hept-3 -yl)piperazine-1-carboximidamide for treatment of obesity or type II diabetes
11/01/2005US6960581 1-amino-2-hydroxy-butane or 2-hydroxy-butanamide derivatives
11/01/2005US6960578 Glutamate receptor antagonists
11/01/2005US6960573 Vitamin D3 derivative and treating agent for inflammatory respiratory disease using same
11/01/2005US6960561 Polypeptide mixture containing preservative, surfactant and stabilizer
11/01/2005US6960558 Method of screening for anti-obesity agents using ciliary neutrophic factor receptor
11/01/2005US6960444 Transcriptional mediators of blood vessel development and endothelial differentiation
11/01/2005US6960343 Nucleotide sequences coding polypeptide for use in the treatment of necrosis, septic shock and inflammation
11/01/2005US6960341 Bifidobacteria and preparations containing them
11/01/2005CA2072915C Vitamin d compound, method of preparing this compound and intermediate therefor
10/2005
10/27/2005WO2005100987A1 Novel ligand of g protein coupled receptor protein and use thereof
10/27/2005WO2005100563A1 Follistatin mutant polypeptide
10/27/2005WO2005100331A2 Antidiabetic agents
10/27/2005WO2005099760A1 Solid pharmaceutical preparation
10/27/2005WO2005099759A1 Medicine for prevention and/or treatment of arteriosclerosis
10/27/2005WO2005099746A1 Method for modulating appetite
10/27/2005WO2005099735A1 Lipase inhibitor containing component of leaf of hardy rubber tree
10/27/2005WO2005099734A1 Lipase inhibitor containing water extract from leaf of hardy rubber tree
10/27/2005WO2005099686A1 Edible composition having effects of promoting the production and release of calcitonin gene-related peptide
10/27/2005WO2005099682A1 Preparations for external use
10/27/2005WO2005099681A1 Tablet containing branched chain amino acid and process for producing the same
10/27/2005WO2005099671A2 Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles
10/27/2005WO2005099486A1 Process for preparing lagerstroemia speciosa l. extract
10/27/2005WO2005099485A1 Health food, process for producing the same and dried matter or extract
10/27/2005WO2005072045A3 The combined use of glp-1 agonists and gastrin for regulating blood glucose levels
10/27/2005WO2003023008A8 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
10/27/2005US20050240023 Cathepsin cysteine protease inhibitors
10/27/2005US20050239887 Pharmaceutical composition that is used to control blood glucose in patients with type 2 diabetes
10/27/2005US20050239884 Compositions comprising hmg-coa reductase inhibitor
10/27/2005US20050239883 Composition for lowering internal lipid content
10/27/2005US20050239872 1,5-distributed pyrrolid-2-one derivatives for use as ep4 receptor agonists in the teatment of eye diseases such as glaucoma
10/27/2005US20050239856 Method for prophylaxis and treatment of diabetic complications with 4{alpha-hydroxy-2-methyl-5-(1-imidazolyl)benzyl}-3,5-dimethylbenzoic acid and derivatives
10/27/2005US20050239854 Body weight gain inhibitors
10/27/2005US20050239852 2-(3-aminoaryl)amino-4-aryl-thiazoles and their use as c-kit inhibitors
10/27/2005US20050239851 Substituted benzoxazoles as estrogenic agents
10/27/2005US20050239849 Substituted phenoxyacetic acids
10/27/2005US20050239835 controlling weight gain; 1-(1-amino-2-phenylethylcarbonyl)-4-cyclohexylpiperidine compounds
10/27/2005US20050239828 Spirocyclic amides as cannabinoid receptor modulators
10/27/2005US20050239824 Triple monoamine reuptake inhibitors for the treatment of chronic pain
10/27/2005US20050239815 Receptor or non-receptor; 5,6,7,8,9,10-hexahydro-6,9-(epiminomethano) benzo[ alpha ][8]annulenes; anticarcinogenic, antidiabetic, antiproliferative agents; autoimmune and Crohn's diseases, acromegaly, aging resistance; coadminister tamoxifen, raloxifene, taxol, trastuzumab, tirofiban or a COX-2 inhibitor
10/27/2005US20050239802 E.g., 6-{2-[5-Chloro-2-(2,4-difluorobenzyloxy)- phenyl]cyclopent-1-enyl}-pyridine-2-carboxylic acid, used to treat prostaglandin mediated diseases that include inflammatory, neuropathic or visceral pain
10/27/2005US20050239791 Substituted 1-heteroaryl-4-substituted piperazine and piperidine analogues
10/27/2005US20050239789 2-(9-bromo-3,4,10,10a-tetrahydro-1H-pyrazino[1,2-a]indol-2-yl)-cyclobutanone; treating disorders of the central nervous system, damage to the central nervous system, cardiovascular disorders, gastrointestinal disorders, diabetes insipidus, obesity and sleep apnea
10/27/2005US20050239780 Tetrahydropyran derivative
10/27/2005US20050239777 Quinazoline derivatives and pharmaceutical compositions containing them
10/27/2005US20050239776 Tachykinin receptor antagonists
10/27/2005US20050239768 Trans-(4a,9b)-2-methyl-2,3,4,4a,5,9b-hexahydro-1H-pyrido[4,3-b]indol-6-yl-4-methylphenyl sulfide; 5-HT2 receptor modulation; schizophrenia, anxiety, depression, and migraines
10/27/2005US20050239766 e.g. 1-(4-fluorophenyl)-3-[3-(4-fluorophenyl)-3-hydroxypropyl]-4-{4-[N-((R)- alpha -{N-(S)-[1-(carboxy)-2-(hydroxy)ethyl]carbamoyl}benzyl)carbamoylmethoxy]phenyl}azetidin-2-one; cholesterol absorption inhibitor; hyperlipidaemia
10/27/2005US20050239711 Selective linear peptides with melanocortin-4 receptor (MC4-R) agonist activity
10/27/2005US20050239696 Gmg-3 gmg-4 and gmg-6 polynucleotides and polypeptides and uses thereof
10/27/2005US20050239170 Alpha-MSH related compounds and methods of use
1 ... 690 691 692 693 694 695 696 697 698 699 700 701 702 703 704 705 706 707 708 709 710 ... 1298